Synthesis, Biological Assessment and Molecular Modeling of Racemic QuinoPyranoTacrines for Alzheimer's Disease Therapy

Affiliation auteurs!!!! Error affiliation !!!!
TitreSynthesis, Biological Assessment and Molecular Modeling of Racemic QuinoPyranoTacrines for Alzheimer's Disease Therapy
Type de publicationJournal Article
Year of Publication2018
AuteursChioua M, Serrano E, Dgachi Y, Martin H, Jun D, Janockova J, Sepsova V, Soukup O, Moraleda I, Chabchoub F, Ismaili L, Iriepa I, Marco-Contelles J
JournalCHEMISTRYSELECT
Volume3
Pagination461-466
Date PublishedJAN 17
Type of ArticleArticle
ISSN2365-6549
Mots-clésAlzheimer's disease, Biological Evaluation, Molecular modeling, QuinoPyranoTacrines, synthesis
Résumé

In this report we describe the synthesis, biological evaluation and molecular modeling of new tacrine analogues such as QuinoPyranTacrines (QPTs), designed by juxtaposition of 1,4-naphthoquinone and tacrine. From these results we have identified QPT16 as a permeable, selective human acetylcholinesterase inhibitor [IC50= 1.1 +/- 0.15 mu M], 3.5-fold less-hepatotoxic than tacrine at 1000 mu M concentration, and consequently, a potential new hit-compound for further investigation targeted to find a new agent for AD therapy.

DOI10.1002/slct.201702781